Pages that link to "Q46420596"
Jump to navigation
Jump to search
The following pages link to Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study (Q46420596):
Displaying 50 items.
- Continuous glucose monitoring systems for type 2 diabetes mellitus (Q24187648) (← links)
- Continuous glucose monitoring systems for type 1 diabetes mellitus (Q24203866) (← links)
- Continuous glucose monitoring systems for type 2 diabetes mellitus (Q24235570) (← links)
- Integrated insulin pump therapy with continuous glucose monitoring for improved adherence: technology update (Q26785492) (← links)
- Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials (Q26824430) (← links)
- Continuous glucose monitoring in insulin-treated patients in non-ICU settings (Q27001160) (← links)
- Continuous glucose monitoring: evidence and consensus statement for clinical use (Q27022628) (← links)
- On the Slow Diffusion of Point-of-Care Systems in Therapeutic Drug Monitoring (Q27024074) (← links)
- Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile (Q27687563) (← links)
- Continuous glucose monitoring: current use and future directions (Q30354773) (← links)
- Closed-Loop Glucose Control: Psychological and Behavioral Considerations (Q30424290) (← links)
- Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes (Q30455250) (← links)
- Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes (Q31121925) (← links)
- Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis. (Q31149131) (← links)
- Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy (Q33403231) (← links)
- Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas (Q33556720) (← links)
- Accuracy of a new real-time continuous glucose monitoring algorithm (Q33674517) (← links)
- Sense and nonsense in sensors. (Q33696734) (← links)
- Continuous Glucose Monitoring and Global Reimbursement: An Update (Q33786148) (← links)
- Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial (Q33873080) (← links)
- The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics (Q33945186) (← links)
- Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data (Q33954163) (← links)
- Assessing the effectiveness of 3 months day and night home closed-loop insulin delivery in adults with suboptimally controlled type 1 diabetes: a randomised crossover study protocol (Q34151693) (← links)
- New-generation diabetes management: glucose sensor-augmented insulin pump therapy (Q35224968) (← links)
- Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture (Q35336885) (← links)
- Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Trials (Q35337121) (← links)
- Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties (Q35428773) (← links)
- Use of sensors in the treatment and follow-up of patients with diabetes mellitus. (Q35863010) (← links)
- Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy (Q35682802) (← links)
- A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years (Q35688182) (← links)
- Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia (Q35751626) (← links)
- Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study (Q35898281) (← links)
- Continuous glucose monitoring for patients with diabetes: an evidence-based analysis. (Q36040243) (← links)
- HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Da (Q36159014) (← links)
- The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System (Q36291631) (← links)
- Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study (Q36340521) (← links)
- The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial (Q36353388) (← links)
- Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. (Q36605704) (← links)
- Are Systematic Reviews and Meta-Analyses Appropriate Tools for Assessing Evolving Medical Device Technologies? (Q36638904) (← links)
- The role of continuous glucose monitoring in the care of children with type 1 diabetes (Q36777662) (← links)
- Health-Related Quality of Life and Treatment Satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) Trial (Q36837487) (← links)
- Diabetes Technology: Uptake, Outcomes, Barriers, and the Intersection With Distress. (Q37054720) (← links)
- Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set (Q37080640) (← links)
- A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy (Q37154369) (← links)
- A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system (Q37192444) (← links)
- Influences on Technology Use and Efficacy in Type 1 Diabetes (Q37288564) (← links)
- Improved glycemic control through continuous glucose sensor-augmented insulin pump therapy: prospective results from a community and academic practice patient registry (Q37404609) (← links)
- Effective assessment of diabetes control using personal glucometers (CONTOURLINK, Bayer, Germany; CALLA, Wellion, Austria; LINUS, Agamatrix, USA). (Q37433075) (← links)
- Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study (Q37437141) (← links)
- Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump (Q37453111) (← links)